Skip to main content
Funding

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (27${count})

  • Rapid Response Innovation Awards, 2008
    Generation of a dorsal motor nucleus X (DMX) specific pre-clinical model of alpha synuclein overexpression to study the etiology of autonomic dysfunction in PD

    Objective/Rationale:
    The etiology for the non-motor symptoms in PD, such as autonomic instability, sleep disturbance, and constipation, remain poorly understood. In their recent studies of PD...

  • Dopamine-Non-Responsive Symptoms of Parkinson's Disease, 2006
    Non-dopaminergic imaging biomarkers as tools for early PD - testing the Braak Hypothesis

    Many recent studies have suggested that we need to expand research in Parkinson's disease to study symptoms other than the typical motor symptoms of tremor, slowness of movements, stiffness, and...

  • Therapeutic Pipeline Program, 2021
    Dietary Interventions to Slow and Improve Parkinson’s Symptoms by Restructuring the Gut Microbiome and Decreasing Inflammation

    Study Rationale:
    There is a link between the gut and the brain in Parkinson’s disease (PD), and gut bacteria may play an important role. Gut bacteria they affect the bowel mucus barrier, produce...

  • Research Grant, 2023
    Developing Wiring Diagrams of the Brain-Body Connection

    Study Rationale: Individuals with Parkinson’s disease (PD) can show a variety of symptoms, including: resting tremors, alterations in directed hand movements, and treatment-induced dyskinesias; loss...

  • Therapeutic Pipeline Program, 2020
    Target Validation Studies for the Discovery of Novel Small Molecule Therapeutics with the Potential to Modify Disease Outcome by Inhibiting Bacterial Amyloid Protein-induced Alpha-synuclein Aggregation and Associated Neuronal Toxicity

    Study Rationale:
    Patients with Parkinson’s disease frequently report serious gastrointestinal (GI) symptoms, most commonly constipation, which are not well treated with currently available medicine...

  • Research Grant, 2017
    A Study of Gastrointestinal Impairment in Parkinson's Disease

    Study Rationale:
    Gastrointestinal (GI) symptoms, such as constipation, nausea and vomiting, are common in Parkinson's disease (PD), but the cause of these symptoms is not entirely clear. Slow movement...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.